Translate page

EHA 2017

July 2017 - Important CML news was among the scientific data presented at the 22nd Meeting of the European Association of Hematology (EHA) in Madrid. This included; data on the use of dasatinib in children and adolescents, new data comparing bosutinib with imatinib in frontline therapy and the 24-month results from the British Destiny Study. 

We are delighted to provide you with summaries of this key CML information presented at the congress and to have two CML experts sharing their personal perspectives of the EHA highlights.

Top CML stories from EHA 2017

We are pleased to provide you with three stories featuring key CML studies presented at the oral presentations on clinical studies in CML.

EHA congress materials on CML

If you attended the EHA meeting you can log into the EHA Learning Center with your EHA login details and create a free account. This gives you access to CML related e-posters - biology, e-poster - clinical, abstracts - biology, abstracts - clinical and other publications from the meeting.